Trial Information
Current as of March 11, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Eye treated with MIMS® Device as a standalone procedure
- • 2. MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024
About Sanoculis Ltd
Sanoculis Ltd. is a pioneering biopharmaceutical company dedicated to advancing innovative therapies for ocular diseases. With a strong focus on research and development, Sanoculis leverages cutting-edge science and technology to address unmet medical needs in the field of ophthalmology. Committed to improving patient outcomes, the company collaborates with leading experts and institutions to drive clinical trials that explore novel treatment options. Sanoculis aims to enhance the quality of life for individuals affected by vision-related conditions through its robust pipeline of therapeutic candidates.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yerevan, , Armenia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
